Arbutus Biopharma Appoints Lindsay Androski as CEO Amid Leadership Restructuring
WARMINSTER, PA — Arbutus Biopharma Corporation (Nasdaq: ABUS) has announced significant changes to its leadership team, naming Lindsay Androski, J.D., M.B.A., as Chief Executive Officer. Ms. Androski succeeds Michael J. McElhaugh, …
Arbutus Biopharma Appoints Lindsay Androski as CEO Amid Leadership Restructuring Read More